Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| BT-20 | LY3023414 | 10.0 | -0.6210 | 0.55919 |
| HCC1500 | Senexin B | 3.16227766017 | -0.6189 | -0.09971 |
| MDA-MB-453 | LY3023414 | 10.0 | -0.6182 | 0.39060 |
| HCC1428 | LY3023414 | 0.316227766 | -0.6120 | 0.03160 |
| MDA-MB-361 | LY3023414 | 1.0 | -0.6111 | 0.27579 |
| BT-20 | LY3023414 | 10.0 | -0.6090 | 0.52693 |
| MDA-MB-361 | LY3023414 | 0.316227766017 | -0.6074 | 0.13022 |
| SK-BR-3 | MK 1775 | 10.0 | -0.6053 | 0.21933 |
| MDA-MB-134-VI | THZ531 | 1.0 | -0.6052 | 0.16698 |
| SK-BR-3 | THZ531 | 1.0 | -0.6045 | 0.24632 |
| HCC1500 | MK 1775 | 1.0 | -0.6044 | -0.06976 |
| HCC1500 | GSK2334470 | 0.00316227766017 | -0.6044 | -0.16582 |
| BT-20 | Alvocidib | 1.0 | -0.6023 | 0.56235 |
| HCC1419 | LY3023414 | 10.0 | -0.6005 | 0.19542 |
| HCC70 | Alvocidib | 0.316227766 | -0.6002 | 0.34475 |
| AU565 | Alvocidib | 1.0 | -0.6000 | 0.41960 |
| HCC1428 | Alvocidib | 0.316227766 | -0.5978 | -0.00565 |
| HCC1428 | THZ1 | 0.316227766 | -0.5978 | 0.07464 |
| BT-20 | Alvocidib | 1.0 | -0.5967 | 0.54204 |
| HCC1500 | BMS-265246 | 0.00316227766017 | -0.5944 | -0.16524 |
| HCC1428 | AZD2014 | 3.16227766 | -0.5930 | 0.03308 |
| MDA-MB-134-VI | AZD2014 | 3.16227766017 | -0.5928 | 0.17359 |
| BT-20 | LY3023414 | 10.0 | -0.5902 | 0.54538 |
| HCC1395 | THZ531 | 1.0 | -0.5892 | 0.22010 |
| HCC1500 | GSK2334470 | 0.0316227766017 | -0.5843 | -0.21683 |